Dare Bioscience Inc expected to post a loss of 10 cents a share - Earnings Preview

Dare Bioscience

26/03/2024 13:48

* Dare Bioscience Inc  DARE.OQ   DARE.O  is expected to show
a
rise in quarterly revenue when it reports  results on March 28
for the period ending December 31 2023
    * The San Diego California-based  company is expected to
report
revenue of $1.838 million, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Dare Bioscience Inc is
for a
loss of 10 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dare
Bioscience
Inc is $5.00​, above​ its last closing price of $0.52. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.10       -0.10      -0.09     Beat    8.2
 Jun. 30 2023  -0.10       -0.10      -0.10     Met     -1.7
 Mar. 31 2023  -0.10       -0.10      -0.09     Beat    10​
 Dec. 31 2022  -0.14       -0.14      -0.19     Missed  -39
 ​​Sep.        -0.11       -0.12      -0.08     Beat    31.9
 30 2022                                                
 Jun. 30 2022  -0.06       -0.06      0.00      Beat    100​
 Mar. 31 2022  -0.14       -0.14      -0.10     Beat    29.8
 Dec. 31 2021  -0.20       -0.15      -0.18     Missed  -23.3
 This summary was machine generated March 26 at 13:48 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)